President Trump’s October 2025 directive to resume U.S. nuclear explosive testing “on an equal basis” with Russia and China remains the central political driver behind this market. Subsequent statements from the Energy Secretary clarified that current efforts focus on non-critical system tests rather than nuclear detonations, while NNSA officials and lab directors have reiterated no technical or military requirement for explosive tests. Recent non-nuclear chemical high-explosive experiments at the Nevada National Security Site aim to improve detection of low-yield foreign tests, not conduct U.S. detonations. Congressional opposition, including Senate visits and nominee commitments against testing, combined with preparation timelines of 6–36 months, continues to constrain near-term action through late 2026. Trader consensus reflects these institutional and procedural hurdles.